Ladenburg Thalmann Financial Services’s VistaGen Therapeutics VTGN Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio VTGN Stock Details VTGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$112K	Sell	5,424 -400	-7%	-$10.1K	﹤0.01%	2929
2019 Q3	$187K	Hold	5,824	–	–	﹤0.01%	2519
2019 Q2	$126K	Sell	5,824 -6	-0.1%	-$159	﹤0.01%	2810
2019 Q1	$224K	Buy	5,830 +1,293	+28%	+$56.4K	﹤0.01%	2309
2018 Q4	$204K	Buy	4,537 +383	+9%	+$20.9K	﹤0.01%	2232
2018 Q3	$180K	Buy	4,154 +674	+19%	+$27.3K	﹤0.01%	2394
2018 Q2	$97K	Hold	3,480	–	–	﹤0.01%	2776
2018 Q1	$97K	Hold	3,480	–	–	﹤0.01%	2776
2017 Q4	$116K	Buy	3,480 +1,977	+132%	+$65.2K	﹤0.01%	2623
2017 Q3	$72K	Hold	1,503	–	–	﹤0.01%	2821
2017 Q2	$84K	Hold	1,503	–	–	﹤0.01%	2627
2017 Q1	$88K	Buy	1,503 +1,184	+371%	+$95.9K	﹤0.01%	2488
2016 Q4	$36K	Hold	319	–	–	﹤0.01%	3087
2016 Q3	$40K	Buy	319 +71	+29%	+$7.71K	﹤0.01%	2971
2016 Q2	$29K	Buy	+248	New	+$28.4K	﹤0.01%	3091

Other funds holding VTGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return

Ladenburg Thalmann Financial Services's VTGN Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its VistaGen Therapeutics (VTGN) stake by 6.9% in Q4 2019, selling an estimated $10.1K and leaving 5,424 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #2929.

Ladenburg Thalmann Financial Services first reported a position in VTGN in Q2 2016 and has held it in 15 quarters since. The position peaked at $224K in Q1 2019. 25 funds tracked by Wall St. Rank hold VTGN as of Q4 2019.

Ladenburg Thalmann Financial Services held 5,424 shares of VistaGen Therapeutics worth $112K as of Q4 2019.
Ladenburg Thalmann Financial Services sold 400 VistaGen Therapeutics shares in Q4 2019, an estimated $10.1K.
VistaGen Therapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #2929 holding.
Ladenburg Thalmann Financial Services first reported a position in VistaGen Therapeutics in Q2 2016 and has held it in 15 quarters since.
Ladenburg Thalmann Financial Services's VistaGen Therapeutics position peaked at $224K in Q1 2019.
25 funds tracked by Wall St. Rank held VistaGen Therapeutics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.